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Abstract
Background: Cluster headache is famous for attacks with seasonal and diurnal periodicity. This diurnal and seasonal
variation might be related to sunlight and vitamin D metabolism. We investigated the serum vitamin D levels in
patients with cluster headache.
Methods: We enrolled patients with cluster headache and age- and sex-matched migraineurs and normal controls.
From October 2016 to March 2018, non-fasting serum 25(OH)D concentrations were measured using a chemiluminescent
immunoassay. Vitamin D deficiency was defined as a concentration < 20 ng/mL.
Results: The study enrolled 28 patients with cluster headache, 36 migraineurs, and 36 normal controls. In the patients
with cluster headache, the serum 25(OH)D concentration averaged 14.0 ± 3.9 ng/mL and 92.8% had vitamin D deficiency.
There was no significant difference among the patients with cluster headache, migraineurs, and controls. In the patients
with cluster headache, there was no difference in the serum 25(OH)D concentrations between men and women, cluster
and remission periods, first and recurrent attack, presence and absence of daily or seasonal periodicity, and 3-month
recurrence. In the 14 patients with seasonal periodicity, patients with periodicity of winter to spring had a trend of lower
serum 25(OH)D concentrations than those with periodicity of summer to autumn (12.30 ± 1.58 vs. 16.96 ± 4.69 ng/mL,
p = 0.097).
Conclusions: Vitamin D deficiency is common in patients with cluster headache, but the role of vitamin D
deficiency is uncertain, except for its seasonal influence.
Keywords: Vitamin D, Deficiency, Cluster headache, Migraine
Background
Vitamin D is produced in the skin after oral absorption
and exposure to sunlight. It is transformed by the liver
and kidneys and plays a crucial role in promoting bone
and muscle health. Vitamin D deficiency is a global health
issue and is associated with inflammation, autonomic
function, autoimmune disorders, chronic pain, cancer, and
vascular and neurological disorders, in addition to its skel-
etal roles [1–6].
The estimated prevalence of vitamin D deficiency in
North America, Europe and Australia is as high as 20–
50% [7–13]. Vitamin D deficiency is more common in
Korea (37° N) where the prevalence in male and female
adult workers was 69.5 and 83.1%, respectively [14]. The
determinants of vitamin D levels are the amount of skin
exposure, followed by location, season, personal ultravio-
let radiation exposure, vitamin D supplementation, body
mass index, and physical activity [15].
A high prevalence of all kinds of headache has been
associated with high latitude, suggesting a relationship
with vitamin D [16]. However, the inter-relationships of
vitamin D deficiency and headache are still uncertain.
The studies of vitamin D in primary headache disorders
have focused mainly on migraine, although there is no
systematic evidence of an association between vitamin D
deficiency and migraine [17–19]. There are case reports
of migraine patients who improved with vitamin D sup-
plementation [20, 21]. Simvastatin plus vitamin D has
been reported to be effective for preventing headache in
adults with episodic migraine in randomized clinical tri-
als [22]. Dysfunction of vitamin D-binding protein and
polymorphism of the vitamin D receptor gene have been
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reported in patients with migraine, while the relationship
between the serum vitamin D level and headache fre-
quency in migraine patients is controversial [23–25].
Tension-type headache is the most common primary
headache disorder, accounting for most non-migraine
headache in population studies. In the Norwegian popu-
lation, non-migraine type headache was associated with
low vitamin D levels with an odds ratio of 1.20 in the
lowest quartile compared with the highest quartile
group, whereas no significant association was found be-
tween migraine and the vitamin D levels [17]. There are
also reports that chronic tension-type headache was as-
sociated with vitamin D deficiency [26–28].
Cluster headache shows a seasonal predilection, with
nocturnal attacks [29–31]. The diurnal and seasonal vari-
ation might be related to sunlight and vitamin D metabol-
ism, suggesting a role for vitamin D in cluster headache.
There are no published studies of vitamin D in cluster
headache, although a poster presentation showed that an
anti-inflammatory regimen of vitamin and mineral supple-
ments including vitamin D3 was effective in preventing
cluster headaches [32]. Therefore, we investigated the
serum vitamin D level in patients with cluster headache
and the relationship between vitamin D deficiency and
headache parameters compared with migraineurs and
healthy controls.
Methods
Subjects
We enrolled patients with cluster headache and age- and
sex-matched migraine patients as headache controls and
normal controls in a case–control design. This study col-
lected data from patients with cluster headache and mi-
graine treated in the headache clinics of Chuncheon,
Dongtan, and Kangnam Sacred Heart Hospitals of Hallym
University College of Medicine from October 2016 to
March 2018. All participants were between 20 and 65 years
of age, and they were examined and classified according to
the beta version of the International Classification of Head-
ache Disorders-3 (ICHD-3β) [33] by a board-certified neur-
ologist based on the patient history, a neurological
examination, and neuroimaging studies. The control group
consisted of volunteers matched for age, gender, and season
enrolled. We recruited the control group via advertisements
such as posted notices in the hospital. Control participants
were required to be headache free (less than 1 headache
day per month for an average of 1 year) with no history of
primary or secondary headache disorder by the ICHD-3β
[31, 33]. Exclusion criteria included subjects who took a
vitamin D supplement or medication that influences vita-
min D metabolism (e.g., antiepileptic drugs, rifampin, anti-
retroviral drugs, etc.), severe obesity [body mass index
(BMI) > 30], thyroid or parathyroid disease, diabetes, and
severe liver or renal disease.
The study protocol and informed consent form were
reviewed and approved by the Institutional Review
Board of each hospital (2016-439-I). Written informed
consent was obtained from all participants before enrol-
ling them in the study.
Demographic data and questionnaire
Demographic data were obtained from all groups, includ-
ing age, sex, height, weight, place of residence, occupation,
level of education, and smoking habit. The data collected
on headache patients included frequency of attacks (per
month), average headache duration (hours), severity of
pain [assessed with a visual analogue scale (VAS) range 0–
10], and days per month using abortive medication. The
patients with cluster headache completed a detailed
semi-structured questionnaire on the headache character-
istics, such as autonomic symptoms, diurnal periodicity,
time of propensity, and seasonal periodicity. We contacted
the patients after at least 3 months and collected data on
the recurrence of headache. Eligible patients were inter-
viewed at follow-up outpatient appointments or by tele-
phone. The headache group completed the Headache
Impact Test-6 (HIT-6) to measure headache-related im-
pact, Patient Health Questionnare-9 (PHQ-9) to assess de-
pression, Generalized Anxiety Dirorder-7 (GAD-7) to
assess anxiety, and Pittsburgh Sleep Quality Index (PSQI)
to measure the quality of sleep [34–37].
Measurement and analysis of vitamin D
Non-fasting venous blood samples were collected at the
baseline examinations. Serum 25(OH)D concentrations
were measured with a chemiluminescent immunoassay
using the ARCHITECT i4000 SR (Abbott Diagnostics, IL,
USA). The intra- and interassay coefficients of variation of
the measurements were 1.7–2.8 and 2.7–4.1%, respectively.
The assay was standardized against NIST Standard Refer-
ence Material 2972 (NIST, Gaithersburg, ME, USA) and
certified by the Centers for Disease Control and Prevention
Vitamin D Standardization Program [38]. Vitamin D defi-
ciency was defined as a 25(OH)D < 20 ng/mL, insufficiency
as 21–29 ng/mL, and ideal range as 30–50 ng/mL.
The time of the day, month, and year when the vitamin
D assessment was performed was recorded [39, 40]. Most
experts define vitamin D deficiency as serum 25(OH)D
vitamin D levels < 20 ng/mL, although there is no consen-
sus on the optimal serum vitamin D levels [41–44]. A cut-
off value of 20 ng/mL was used to divide the samples into
“deficient” and “normal” groups in this study [14].
Statistics
Analysis of variance (ANOVA) was used to compare
demographic and headache parameters among groups,
after confirming the normality of the distribution
using the Shapiro-Wilk test. If the normality of the
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distribution was not confirmed, the Kruskal-Wallis,
chi-square test or Fisher’s exact test were used to
compare data between groups, where appropriate.
Serum vitamin D concentrations in subjects with CH,
migraine, and controls were compared using analysis
of covariance (ANCOVA), with adjustment for poten-
tial confounders. The correlations between the serum
25(OH)D concentration and various clinical features
were assessed using Pearson’s or Spearman correlation
coefficient based on the normality of the distribution.
To compare vitamin D concentration according to
the headache parameters among the CH group, the
Mann-Whitney test was used. ANOVA was used to
compare vitamin D concentrations between subgroups
in CH patients. Using linear regression analysis, we
calculated the odds ratios of vitamin D levels associ-
ated with the headache variables. The variables that
showed statistical correlations with the vitamin D
levels in the univariate analyses, and factors that are
known to affect the vitamin D level, were included in
the multivariate regression analysis. Linear regression
was used to assess the seasonal propensity of serum
25(OH)D concentrations with factors known to affect
vitamin D levels (age, male, current smoker, sampling
time) [45]. A p-value < 0.05 was considered statisti-
cally significant. All analyses were performed using R
version 3.5.0 for Windows (R Foundation for Statis-
tical Computing, Vienna, Austria. http://www.r-projec-
t.org/) and RStudio version 1.1.442.
Results
Comparison of demographics and vitamin D levels in
patients with cluster headache, migraine, and controls
The study enrolled 28 patients with cluster headache, 36
migraineurs, and 36 normal controls. No significant dif-
ferences were found in the CH and migraine patients
compared with the controls in terms of age (38.2, 35.1,
and 35.4 years, respectively) or sex (proportion male
85.7, 80.6, and 88.9%, respectively). In addition, there
were no differences in BMI, smoking status, sampling
season, and sampling time zones (7-10 AM, 11 AM-1 PM,
2-5 PM) among the three groups (Table 1).
The serum 25(OH)D concentrations were 14.0 ±
3.9 ng/mL in the patients with CH, 14.7 ± 5.9 ng/mL in
the migraineurs, and 14.6 ± 7.4 ng/mL in the normal
controls (p = 0.884). After adjustment for potential con-
founders (sex, age, sampling season, current smoking)
by ANCOVA, the serum 25(OH)D concentrations were
not different between groups (data not shown, p =
0.853). Vitamin D deficiency was present in 92.8% of the
patients with CH, 80.6% of the migraineurs, and 83.3%
of the normal controls (p = 0.771) There were no signifi-
cant differences in distribution of serum 25(OH)D con-
centrations between patients with CH, migraine, and
controls (Table 1).
Serum 25(OH)D concentrations were higher in those
with a sampling season from summer to autumn than
those with a sampling season from winter to spring (15.6 ±
5.2 ng/mL vs. 13.3 ± 6.5 ng/mL, p = 0.003). No differences
Table 1 Demographic features and vitamin D parameters of the patients with cluster headache, migraineurs, and normal controls
Cluster Headache (n = 28) Migraine (n = 36) Normal controls (n = 36) p-value
Age, years 38.2 ± 8.5 35.1 ± 8.2 35.4 ± 9.1 0.189
Men (%) 24 (85.7) 29 (80.6) 32 (88.9) 0.607
BMI, kg/m2 23.3 ± 2.8 23,6 ± 3.7 24.1 ± 3.2 0.583
Smoking habit (%)a 0.133
Current 17 (63.0) 15 (41.7) 14 (38.9)
ex-smoker 3 (11.1) 2 (5.6) 8 (22.2)
Never 7 (25.9) 19 (52.8) 14 (38.9)
Pain intensity, VAS 8.5 ± 1.8 6.4 ± 1.7 NA < 0.001
Vitamin D deficiency (%) 26 (92.8) 29 (80.6) 30 (83.3) 0.771
Distribution of 25(OH)D concentration 0.236
≥ 30 (ng/mL) 0 1 (2.8) 2 (5.6)
20–29.9 (ng/mL) 2 (7.2) 6 (16.7) 4 (11.1)
10–19.9 (ng/mL) 23 (82.1) 21 (58.3) 19 (52.8)
< 10 (ng/mL) 3 (10.7) 8 (22.2) 11 (30.5)
Sampling seasons 0.349
Winter to spring 15 (53.9) 21 (58.3) 15 (41.7)
Summer to autumn 13 (46.4) 15 (41.7) 21 (58.3)
Values are expressed as mean ± standard deviation or number (%)
VAS visual analogue scale
adata was not available in one patient with CH
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in serum vitamin D concentrations were evident based on
the time of blood sample collection when analyzed at
one-hour intervals (data not shown). Furthermore, there
were no correlations between serum 25(OH)D concentra-
tions and age, BMI, GAD-7 score, or PHQ-9 score, nor
were any differences of the level observed between sexes.
Comparison of vitamin D levels in the patients with
cluster headache according to clinical factors
In patients with CH, there was no difference in the serum
25(OH)D concentrations between men and women, clus-
ter and remission periods, first and recurrent attack, pres-
ence and absence of daily or seasonal periodicity, and
3-month recurrence (p > 0.05). In the 14 patients with sea-
sonal periodicity, patients with periodicity of winter to
spring had a trend toward lower serum 25(OH)D concen-
trations than those with periodicity of summer to autumn
(12.30 ± 1.58 vs. 16.96 ± 4.69 ng/mL, p = 0.097, Table 2).
Vitamin D levels were significantly lower in the sub-
group with sampling season between winter to spring rela-
tive to other groups. Therefore, we analyzed vitamin D
levels in the CH subgroups according to seasonal propen-
sity, and by sample season for the 22 CH patients with re-
currence (Table 3). There were significant differences in
vitamin D levels between six groups; however, the differ-
ences between sampling seasons were not significant.
There was no correlation between the vitamin D level and
daily frequency, average weeks of cluster period, total bout
of cluster period, or HIT-6, GAD-7, or PHQ-9 score.
Clinical factors associated with vitamin D levels
The univariate linear analysis showed that sampling
from summer to autumn and seasonal propensity for
summer to autumn showed significant correlations with
the vitamin D level. In the multiple linear regression
analysis, however, the significance of seasonal propensity
for summer to autumn was lost after adjusting for the
sampling season. No changes in significance were ob-
served by the multiple linear regression analysis when
controlling for age, current smoking status, and sam-
pling time zone (Additional file 1: Table S1).
Discussion
This study suggested that vitamin D deficiency is very
common in patients with cluster headache compared with
the prevalence of vitamin D deficiency in Korean adults
[14]. However, the significance of vitamin D deficiency is
uncertain, except for a subtle seasonal influence.
A few recent observational studies suggested that low
serum vitamin D levels were related to some headache
disorders, especially migraine and tension-type headache
[24, 28, 46, 47]. One study also reported significant rela-
tions of lifetime prevalence of both migraine and
tension-type headache with latitude [16]. If vitamin D has
any association with headache, the prevalence of headache
should match the seasonal variation in vitamin D levels.
There are data indicating an increased frequency of head-
ache attacks in autumn–winter and the least number of
attacks in summer, although there are few studies on the
seasonal variation of primary headache disorders, such as
migraine and tension-type headache [48–50].
However, the relationship between cluster headache and
vitamin D has not been studied previously, although cluster
headache has characteristic seasonal rhythmicity. Cluster
headache is a primary headache disorder characterized by a
unique seasonal and diurnal periodicity. These characteristic
features of its periodicity suggest involvement of the hypo-
thalamus, the biological clock [51]. In Korea, seasonal pro-
pensity and diurnal periodicity were present in 44.0 and
68.5% of the patients with cluster headache, respectively.
Among patients with seasonal propensity and diurnal peri-
odicity, the most frequently cited season and time was spring
Table 2 Vitamin D levels according to clinical variables in the
patients with cluster headache
25(OH)D, ng/mL p-value
Sex 0.646
Men (n = 24) 13.95 ± 4.08
Women (n = 4) 14.33 ± 2.82
Recurrence 0.300
First episode (n = 6) 14.83 ± 2.42
Recurrent episode (n = 22) 13.78 ± 4.21
Paired comparison 0.421
Cluster period (n = 14) 13.87 ± 3.64
Remission period (n = 14) 14.06 ± 4.56
Diurnal periodicity 0.728
Present (n = 16) 13.69 ± 3.47
Absent (n = 12) 14.41 ± 4.50
Time of propensity 0.125
Nighttime propensity (n = 9) 14.72 ± 3.63
Daytime propensity (n = 7) 11.71 ± 2.63
Recurrence at 3 months 0.562
present (n = 2) 13.00 ± 3.39
absent (n = 26) 14.08 ± 3.97
Seasonal periodicity 0.188
Present (n = 14) 14.63 ± 4.14
Absent (n = 8) 12.29 ± 4.18
Season of cluster period 0.097
Winter to spring (n = 7) 12.30 ± 1.58
Summer to autumn (n = 7) 16.96 ± 4.69
Sampling season 0.001
Winter to spring (n = 15) 11.91 ± 2.63
Summer to autumn (n = 13) 16.41 ± 3.76
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(37.5%) and night (66.4%), respectively [52]. An inverse rela-
tionship between sunshine duration and the monthly inci-
dence of cluster periods was reported in a hospital-based
study [53]. A follow-up population-based study found posi-
tive correlations between average temperature and sunshine
duration with occurrence of cluster periods, and that
temperature was associated with precipitating or priming
cluster periods [30]. Based on previous results, it is possible
that vitamin D and cluster headaches are related. However,
our study did not find significant differences in the vitamin
D level among cluster headache, migraine, and controls. Al-
though there was no significant difference among groups,
the prevalence of vitamin D deficiency was higher in the
cluster headache group than in the migraine and control
groups. This suggests that vitamin D deficiency is very com-
mon in patients with cluster headache compared with the
prevalence of vitamin D deficiency in Korean adults [14].
There was also no significant difference in vitamin D levels
according to clinical variables in the patients with cluster
headache. However, patients with periodicity of winter to
spring had a trend of lower serum 25(OH)D concentrations
than those with periodicity of summer to autumn in patients
with seasonal periodicity. The serum vitamin D level varies
with the season, peaking in May to September. The levels
tend to be lower from November to March [54–56]. There-
fore, we used an arbitrary classification of the sunny season,
i.e., summer to autumn, winter to spring.
The vitamin D receptor and 1α-hydroxylase, the enzyme
responsible for the formation of the active vitamin, are
present in many parts of the central nervous system, includ-
ing the prefrontal cortex, hippocampus, cingulate gyrus,
thalamus, and hypothalamus. The strongest immunohisto-
chemical staining for both the receptor and enzyme was in
the hypothalamus [57]. Vitamin D-binding protein was also
detected in axonal projections throughout the lateral hypo-
thalamus in the rat [58]. The presence of the vitamin D re-
ceptor, 1α-hydroxylase, and vitamin D-binding protein in
the hypothalamus suggests a role of vitamin D deficiency in
the generation of various primary headache disorders. In
addition to the hypothalamus, there is evidence that the
pineal gland has a role in the biological regulation of
circadian rhythms by producing melatonin [59]. Sunshine
has been reported to regulate specific hormonal and neuro-
transmitter levels, including melatonin [60]. Altered
melatonin levels have been documented in cluster headache
and the nocturnal serum melatonin level was decreased
during cluster periods [61]. Based on the characteristic clin-
ical features and proposed mechanisms of cluster headache,
we hypothesized that vitamin D and cluster headache are
related. However, our study failed to find any correlations
between the serum vitamin D levels and headache charac-
teristics, such as the seasonal and circadian rhythmicity of
cluster headache or the association between serum vitamin
D levels and recurrence of cluster headache. To determine
the associations between vitamin D and the recurrence in
cluster headache, a further longitudinal follow-up study of a
larger population is required.
Various factors influence serum vitamin D levels, mak-
ing, it is difficult to speculate on the role of vitamin D in
the pathophysiology of cluster headache. Our study could
not control for all of the environmental and demographic
factors that significantly affect the serum vitamin D levels
There was no information on the exposure of the subjects
to sunlight, their sun protection habits or the extent of
vitamin D supplementation through food, though we did
collect information on smoking status, BMI, sampling
time, and sampling season, all of which are known to in-
fluence vitamin D concentration. We also analyzed the in-
fluence of these variables on serum vitamin D levels.
There were no significant differences in smoking status
and BMI among the three groups. Additionally, current
smoking was not a significant determinant of serum vita-
min D levels in this study population using multivariate
regression analysis. Second, our study had a relatively
small sample size due to the rarity of cluster headache.
This study suggests that the influence of vitamin D may
warrant analysis in a larger cohort of CH patients with
seasonal propensity for winter to spring. This study also
included mostly men, due to a sex-matched research de-
sign, so these findings may not be truly representative of
migraine and normal controls, or generalizable to other
groups. Third, the outcome variables collected, such as
the seasonal propensity, were assessed on self-report by
recall and the classification of the sunny season was arbi-
trary. While we did not obtain fasting serum samples,
there were no significant differences in sampling times
among the three groups based on the time the blood sam-
ples were collected.
Table 3 The 25(OH)D concentration according seasonal propensity and sample seasons in 22 CH patients with recurrence
According to sample
seasons
Seasonal propensity No seasonal
propensity (n = 8)
p-value
Winter to spring (n = 7) Summer to autumn (n = 7)
Winter to spring (n = 12) 12.28 ± 1.93a (n = 5) 13.00 ± 3.39c (n = 2) 9.48 ± 1.61e (n = 5) 0.001
Summer to autumn (n = 10) 12.35 ± 0.07b (n = 2) 18.54 ± 4.38d (n = 5) 16.97 ± 1.82f (n = 3)
One-way analysis of variance (ANOVA) was done based on normal distribution of vitamin D level among 28 patients with cluster headache. According to post-hoc
analysis between 6 groups using Turkey HSD, p-values between a and d was 0.023, p-value between d and e was < 0.001, and p-value between e and f was 0.018.
The other comparisons were not significant
CH cluster headache
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Conclusions
In summary, this is the first report to examine serum
vitamin D levels in patients with CH compared to
those of age-and sex-matched controls controlling for
sampling season as well as other clinical variables..
Our preliminary findings suggest that vitamin D defi-
ciency is very common in patients with cluster head-
ache, but the significance of vitamin D deficiency is
uncertain, except for the subtle seasonal influence.
Further research is needed to determine the role of
vitamin D in CH.
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